Not a good buy right now: price is extended after a strong run and is trading above the first resistance zone.
Trend is bullish, but near-term upside looks capped unless it cleanly breaks and holds above ~47.6.
Options positioning is bullish (call-leaning), yet implied volatility is elevated into earnings, suggesting the market is already pricing a bigger move.
With earnings (QDEC 2025) on 2026-02-10 pre-market, the better risk/reward entry is on a pullback toward ~45 (pivot) rather than chasing at 46.8.
Technical Analysis
Trend: Bullish structure (SMA_5 > SMA_20 > SMA_200) and MACD histogram positive and expanding (0.137), confirming upward momentum.
Momentum/Stretch: RSI(6) = 83.78 indicates an overbought/extended condition—often followed by consolidation or a pullback.
Levels: Pivot/support ~44.999; resistance R1 ~46.588 (already exceeded) and R2 ~47.57 (next key ceiling). Current price 46.76 is between R1 and R2, i.e., closer to resistance than support.
Short-term pattern odds (model): ~80% chance of a flat-to-slightly-down next day (-0.12%) and ~5.56% upside over the next month, implying near-term digestion but a constructive 1-month bias.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Sentiment: OI put/call 0.55 and volume put/call 0.05 = call-skewed, bullish positioning.
Activity: Total option volume 310 with calls 295 vs puts 15 (very call-heavy), but volume appears not especially elevated vs recent averages.
Volatility pricing: IV30 = 37.11 vs historical vol 21.46 and IV percentile 87.65 → options are expensive, consistent with an earnings-driven move being priced in.
Takeaway: Options market leans bullish, but the “premium” being paid for protection/leverage is high into the upcoming event.
Technical Summary
Sell
1
Buy
9
Positive Catalysts
Product/news flow: New product launches (FilmTec MXP RO element; Liveo medical-grade silicone rubber) support a steady innovation cadence and can help sentiment.
Earnings catalyst: QDEC 2025 earnings on 2026-02-10 (pre-market) can re-rate the stock if results/guide confirm post-spin stability.
Analyst tone: Multiple firms have raised price targets into 2026 (generally supportive demand/currency and company-specific improvements).
Relative strength: Stock up ~3.38% while S&P 500 is down ~0.96% today—strong tape for DD.
Neutral/Negative Catalysts
~84 and price sitting near key resistance (R2 ~47.
increases the odds of a near-term stall/pullback.
suggests the market is already anticipating a sizable move around earnings.
Profitability: Net income - $123M (down -127.03% YoY) and EPS -0.29 (down -126.85% YoY) — earnings quality/one-time items or margin pressure are concerns despite revenue growth.
Gross margin: 34.96%, up 0.75% YoY (modest improvement, but not yet translating to bottom-line gains in the snapshot).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend (last ~1 month): Predominantly bullish with multiple price target increases: RBC to $51 (Outperform), Citi to $50 (Buy), JPMorgan to $50 (Overweight), KeyBanc to $51 (Overweight), UBS to $49 (Buy).
Deutsche Bank: “Catalyst Call: Buy” as a short-term idea; notes a meaningful discount to sum-of-the-parts.
Pros (Street view): Post-spin “stability/simplicity,” potential for improved execution into 2026, and supportive sector/currency backdrop.
Cons (Street view): Ongoing cyclical/structural chemical industry headwinds; at least one major house remains more cautious (Morgan Stanley Equal Weight with a lower target previously).
Wall Street analysts forecast DD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DD is 48.27 USD with a low forecast of 44 USD and a high forecast of 51 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Analyst Rating
Wall Street analysts forecast DD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DD is 48.27 USD with a low forecast of 44 USD and a high forecast of 51 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Buy
2 Hold
0 Sell
Strong Buy
Current: 45.680
Low
44
Averages
48.27
High
51
Current: 45.680
Low
44
Averages
48.27
High
51
Deutsche Bank
David Begleiter
Buy
maintain
$46
AI Analysis
2026-01-23
Reason
Deutsche Bank
David Begleiter
Price Target
$46
AI Analysis
2026-01-23
maintain
Buy
Reason
Deutsche Bank analyst David Begleiter placed a "Catalyst Call: Buy" on DuPont as a short-term investment idea. The firm keeps a Buy rating on the name with a $46 price target. The reporting of DuPont's first quarter following the spinoff of its electronics business "will highlight a new era of stability, simplicity and clarity," the analyst tells investors in a research note. Deutsche says the stock shares trade at a 34% discount to its sum-of-the-parts.
RBC Capital
Outperform
maintain
$48 -> $51
2026-01-21
Reason
RBC Capital
Price Target
$48 -> $51
2026-01-21
maintain
Outperform
Reason
RBC Capital raised the firm's price target on DuPont to $51 from $48 and keeps an Outperform rating on the shares as part of a broader research note previewing Q4 for Specialty Chemicals. The firm is expecting in-line prints for Q4 and continues to see company-specific items driving improvement in 2026, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for DD